Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia and Related Disorders or Sleep Disturbance. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at evaluate the long-term safety of NBI-1117568 in adults with schizophrenia. Taking part may give some people access to NBI-1117568, but direct benefit is not guaranteed.
This observational study is following people with Schizophrenia Spectrum Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at confirm this hypothesis using novel blood biomarkers and Positron Emission Tomography (PET) imaging tracers, as well as non-invasive testing for people with Late Onset Schizophrenia or Delusional Disorder. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at investigate the effects of 4-week rTMS treatment on brain and cognitive functions in patients for people with Schizophrenia, Cerebellar Function, or Condition. Some participants may receive Sham instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Schizophrenia and Related Disorders, Mitochondrial Alteration, or Cognitive Impairment to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Cognitive Impairment Associated With Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing stg-rt-fMRI-Neurofeeback with sham-rt-fMRI for people with Schizophrenia, Auditory Hallucination, or Treatment-resistant Schizophrenia. Participants receive stg-rt-fMRI-Neurofeeback or sham-rt-fMRI and complete study visits and assessments.
This study is looking at whether Pimavanserin can help people with Parkinson's Disease Psychosis or Dementia With Lewy Bodies. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia Disorders. Taking part may give some people access to Brief Activities, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether a digital support tool can help people with Schizophrenia. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether Dialectical Behavior Therapy Skills Training can help people with Psychosis or Suicide. Participants take part in Dialectical Behavior Therapy Skills Training and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Motivational Interviewing can help people with Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether Individualized imagery can help people with Psychosis. Participants take part in Individualized imagery and complete follow-up assessments.
This study is comparing Delta-9-THC Very Low Dose with placebo for people with Schizophrenia or Cannabis Use Disorder. Participants receive Delta-9-THC Very Low Dose or placebo and complete study visits and assessments.
This study is looking at whether Active rTMS can help people with Schizophrenia. Participants take part in Active rTMS and complete follow-up assessments.
This study is comparing Rivastigmine Transdermal System with placebo for people with Hallucinations, Auditory or Psychosis. Participants receive Rivastigmine Transdermal System or placebo and complete study visits and assessments.
This study is comparing Ziprasidone with placebo for people with Schizophrenia. Participants receive Ziprasidone or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.